The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Cloning and Characterization of Androgen Receptor Coactivator, ARA55, in Human Prostate
Open accessAbstract
Androgen receptor (AR) is a hormone-activated transcriptional factor that can bind to androgen response elements and that regulates the transcription of target genes via a mechanism that presumably involves cofactors. We report here the cloning of a novel AR coactivator ARA55 using a yeast two-hybrid system. ARA55 consists of 444 amino acids with the predicted molecular mass of 55 kDa and its sequence shows very high homology to mouse hic5, a TGF-beta1-inducible gene. Yeast and mammalian two-hybrid systems and co-immunoprecipitation assays all prove ARA55 can bind to AR in a ligand-dependent manner. Transient transfection assay in prostate cancer DU145 cells further demonstrates that ARA55 can enhance AR transcriptional activity in the presence of 1 nM dihydrotestosterone or its antagonists such as 100 nM 17beta-estradiol or 1 microM hydroxyflutamide. Our data also suggest the C-terminal half of ARA55, which includes three LIM motifs, is sufficient to interact with AR. Northern blot and polymerase chain reaction quantitation showed ARA55 can be expressed differently in normal prostate and prostate tumor cells. Together, our data suggests that ARA55 may play very important roles in the progression of prostate cancer by the modulation of AR transactivation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,387
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80516-4 · Cited by 1,465
Wingo, P. A., Tong, T., & Bolden, S. (1995) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.45.1.8 · Cited by 1,410
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
Taplin, M.-E., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N., & Balk, S. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322101 · Cited by 1,253
Voegel, J. J., Heine, M. J., Zechel, C., Chambon, P., & Gronemeyer, H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00736.x · Cited by 1,079
Veldscholte, J., Ris-Stalpers, C., Kuiper, G. G. J. M., Jenster, G., Berrevoets, C., Claassen, E., van Rooij, H. C. J., Trapman, J., Brinkmann, A. O., & Mulder, E. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80067-1 · Cited by 950
Hong, H., Kohli, K., Trivedi, A., Johnson, D. L., & Stallcup, M. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4948 · Cited by 697
Yeh, S., & Chang, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5517 · Cited by 623
Self-citationRAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2
Li, H., Gomes, P. J., & Chen, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8479 · Cited by 581
Steroid hormone receptors compete for factors that mediate their enhancer function
Meyer, M.-E., Gronemeyer, H., Turcotte, B., Bocquel, M.-T., Tasset, D., & Chambon, P. (1989) · Cell · doi:10.1016/0092-8674(89)90918-5 · Cited by 566
Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
Shibata, H., Spencer, T. E., Oñate, S. A., Jenster, G. W., Tsai, M., Tsai, M., & O’Malley, B. W. (1997) · PubMed · Cited by 520
The LIM domain is a modular protein-binding interface
Schmeichel, K. (1994) · Cell · doi:10.1016/0092-8674(94)90191-0 · Cited by 448
Lee, J. W. (1995) · Molecular Endocrinology · doi:10.1210/me.9.2.243 · Cited by 447
Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.
Gaddipati, J. P., McLeod, D. G. R., Heidenberg, H. B., Sesterhenn, I. A., Finger, M. J., Moul, J. W., & Srivastava, S. (1994) · PubMed · Cited by 363
Zyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton.
Sadler, I., Crawford, A. W., Michelsen, J. W., & Beckerle, M. C. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.6.1573 · Cited by 348
Androgen Receptor: An Overview
Chang, C., Saltzman, A., Yeh, S., Young, W., Keller, E., Lee, H.-J., Wang, C., & Mizokami, A. (1995) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v5.i2.10 · Cited by 333
Self-citationBocquel, M. T., Kumar, V., Stricker, C., Chambon, P., & Gronemeyer, H. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.7.2581 · Cited by 292
From estrogen to androgen receptor: A new pathway for sex hormones in prostate
Yeh, S., Miyamoto, H., Shima, H., & Chang, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5527 · Cited by 267
Self-citationSteroid receptor induction of gene transcription: A two-step model
Jenster, G., Spencer, T. E., Burcin, M. M., Tsai, S. Y., Tsai, M.-J., & O’Malley, B. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7879 · Cited by 264
Shibanuma, M., Mashimo, J., Kuroki, T., & Nose, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47085-8 · Cited by 209
Miyamoto, H., Yeh, S., Wilding, G., & Chang, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7379 · Cited by 203
Self-citationΔ 5 -Androstenediol is a natural hormone with androgenic activity in human prostate cancer cells
Miyamoto, H., Yeh, S., Lardy, H. A., Messing, E. M., & Chang, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11083 · Cited by 147
Self-citationYeh, S., Miyamoto, H., Nishimura, K., Kang, H., Ludlow, J. W., Hsiao, P., Wang, C., Su, C.-Y., & Chang, C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8974 · Cited by 135
Self-citationShibanuma, M., Mochizuki, E., Maniwa, R., Mashimo, J., Nishiya, N., Imai, S., Takano, T., Oshimura, M., & Nose, K. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1224 · Cited by 104
Hydroxyflutamide may not always be a pure antiandrogen
Yeh, S., Miyamoto, H., & Chang, C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61756-4 · Cited by 68
Self-citationChallenges in the Management of Prostate Cancer
CRAWFORD, E. D. (1992) · British Journal of Urology · doi:10.1111/j.1464-410x.1992.tb15865.x · Cited by 44
Cited by
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Self-citationAndrogen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Self-citationThe LIM domain: from the cytoskeleton to the nucleus
Kadrmas, J. L., & Beckerle, M. C. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1499 · Cited by 752
Heemers, H. V., & Tindall, D. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0019 · Cited by 753
Brown, M. C., & Turner, C. E. (2004) · Physiological Reviews · doi:10.1152/physrev.00002.2004 · Cited by 609
Metadata
- Authors
- Fujimoto, N., Yeh, S., Kang, H.-Y., Inui, S., Chang, H.-C., Mizokami, A., & Chang, C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-03
- Volume
- 274
- Issue
- 12
- Pages
- 8316-8321
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2150127705
- Cited by
- 294
- References
- 27
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.